← Every company

Biogen Inc Lobbying

What Biogen Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.

BIIB on carbonthat →
Disclosed spend
$2.8M
across every filing on file
Filings
8
Years covered
1
Firms retained
4

What it lobbies about

Health IssuesMedicare/MedicaidPharmacyTaxation/Internal Revenue CodeTrade (domestic/foreign)Copyright/Patent/Trademark

8 filings

Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.

PeriodLobbying for themDisclosed
20261st Quarter (Jan 1 - Mar 31)BIOGENMedicare/MedicaidHealth Issues$1.5M
20262nd Quarter (Apr 1 - June 30)BIOGENHealth IssuesMedicare/Medicaid$1.1M
20262nd Quarter (Apr 1 - June 30)DLA PIPER LLP (US)PharmacyCopyright/Patent/Trademark$60K
20261st Quarter (Jan 1 - Mar 31)DLA PIPER LLP (US)Taxation/Internal Revenue CodeTrade (domestic/foreign)$60K
20261st Quarter (Jan 1 - Mar 31)FEDERAL STREET STRATEGIES, LLCHealth IssuesMedicare/Medicaid$50K
20262nd Quarter (Apr 1 - June 30)FEDERAL STREET STRATEGIES, LLCHealth IssuesMedicare/Medicaid$50K
20262nd Quarter (Apr 1 - June 30)TODD STRATEGY GROUPMedicare/MedicaidHealth Issues$50K
20261st Quarter (Jan 1 - Mar 31)TODD STRATEGY GROUPMedicare/MedicaidHealth Issues$50K

A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.

More on BIIB

Related datasets